Frequency of Ventricular Arrhythmias in Acute Myocardial Infarction and its relationship with Hypokalemia
Article Sidebar
Main Article Content
Abstract
Introduction: Arrhythmic complications of acute myocardial infarction like ventricular arrhythmias are common and determine the clinical outcome. The associated risk factors like potassium level may help triage the patients to reduce mortality.
Objective: Objectives were to determine the frequency of ventricular arrhythmias in acute myocardial infarction and to compare the frequency of ventricular arrhythmias in normokalemic and hypokalemic patients.
Study design: Cross-sectional survey
Study setting: Study was conducted in Department of Cardiology, Jinnah Hospital, Lahore.
Duration of study: Study duration was six months i.e. from 1st February 2018 to 31st July 2018.
Subjects & Methods: Using consecutive sampling, 370 patients with acute myocardial infarction were included. Development of ventricular arrhythmias was recorded. Rate of development of arrhythmias among normokalemic (serum potassium levels between 3.5mEq/L to 5.0mEq/L) at presentation and hypokalemic was compared. All enrolled patients received standard medical therapy for MI. History of hypertension and smoking was also elicited.
Results: 370 patients were included with mean age of 54.5 ± 9.2 years ranging from 40 to 70 years of age. In our study the frequency of ventricular arrhythmias came out only 16.5%. 21.9% patients with hypokalemia developed ventricular arrhythmias after acute myocardial infarction as compared to 11.4% normokalemic patients (p value< 0.001). There was no significant effect of being older in age, any gender, and hypertensive in our sampled population. Being smoker was significantly associated with development of arrhythmia.
Conclusion: It is concluded that patients with hypokalemia are at greater risk of developing ventricular arrhythmias after acute myocardial infarction.
Downloads
Article Details
Copyright (c) 2018 Ali M, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
World Health Organization (2013) Global atlas on cardiovascular disease prevention and control. Geneva, World Health Organization, 2011. Available on. Link: https://goo.gl/ipHUjK
World Health Organization (2013) Cardiovascular diseases Fact sheet N°317. Updated March 2013. WHO. Link: https://goo.gl/EZhk3q.
Kjeldsen K, Atar D, Hallén J, Vardas P, Zannad F (2010) Haunsø S.Sudden cardiac death – the challenge to cardiology. Fundam Clin Pharmacol 24: 535-7. Link: https://goo.gl/rBT14Q
Kjeldsen K (2010) Hypokalemia and sudden cardiac death. ExpClinCardiol. 15: 96-99.
Clausen T (2010) Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 24: 595-605. Link: https://goo.gl/EA6y2d
Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R (2008) EPHESUS Investigators Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) Circulation 118: 1643–50.
Su J, Fu X, Tian Y, Ma Y, Chen H, et al. (2012) Serum potassium on admission to the emergency department may be used as a valuable predictor Am J Emergency Med. 30:1089-94.
Unwin RJ, Luft FC, Shirley DG (2011) Pathophysiology and management of hypokalemia: a clinical perspective. Nature Reviews Nephrology 7:75-84. Link: https://goo.gl/ABM61r
McGovern PG, Jacobs DR Jr, Shahar E (2001) Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 104:19-23. Link: https://goo.gl/icu3W6
Adabag AS, Therneau TM, Gersh BJ (2008) Sudden death after myocardial infarction. JAMA 300: 2022-25.